---
schema_version: "secwatch.filing_event.v1"
accession: "0001820144-26-000033"
form_type: "8-K"
ticker: "GRND"
cik: "0001820144"
company_name: "Grindr Inc."
filed_at: "2026-09-30T21:02:31+00:00"
generated_at: "2026-10-12T14:09:21.122477+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Grindr to acquire PurposeMed's Freddie for $250M; up to $70M earnout tied to 2027 targets

## Summary
- $250M deal: $190M cash plus $60M stock (3,851,684 GRND shares at $15.58 VWAP, 12-month lock-up); up to $70M cash earnout on FY2027 targets.
- PurposeMed runs Freddie, a telehealth PrEP provider with >55,000 patients served since 2020, now in all 50 states; 2026 revenue expected >$80M and >$10M Adjusted EBITDA.
- Grindr expects acquisition immaterial to 2026 results; 2027 outlook to come on Q3 earnings call in November; deal expected to close Q4 2026.
- Grindr cites ~400,000 US users already on PrEP and 2M+ more it estimates should be; PrEP reduces HIV risk ~99% and is little/no cost to eligible US patients.
- Freddie leadership to join Grindr Health; shareholder letter projects 40%+ healthcare margin at maturity, mid-teens expected Adjusted EBITDA margin.

## SEC filing metadata
- accession: 0001820144-26-000033
- form_type: 8-K
- ticker: GRND
- cik: 0001820144
- company_name: Grindr Inc.
- filed_at: 2026-09-30T21:02:31+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1820144/000182014426000033/0001820144-26-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1820144/000182014426000033/grnd-20260930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001820144-26-000033
- JSON: https://secwatch.observer/filing/0001820144-26-000033.json
- Plain text: https://secwatch.observer/filing/0001820144-26-000033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.